Blog
Global Advocacy Success Series: Cyrine, Lebanon
31 Aug 2021, 4:19 p.m. in Global Stories, Interviews by Katie Souris
T1International has provided tools and support to ensure Cyrine’s plans are detailed and realistic, and allowed her to connect with other advocates around the world who can offer support and guidance. Read more
Redirecting Guilt into Action
16 Jul 2021, 10:04 a.m. in #insulin4all USA, Global Stories by Elizabeth Roosevelt
It’s crucial that those of us who have access to insulin use our platform and privilege to fight for our community and for the people with diabetes who are solely focused on surviving. We must serve as the voice for the people with diabetes who can’t use their own because they’re bogged down working three jobs and choosing between putting food on the table for their family or insulin. Read more
T1International Comment on Application to Add Long-acting Insulin Analogues to WHO EML
17 Jun 2021, 9:03 a.m. in News & Statements by T1International
The WHO justifying inaction by saying it will not be adequate fails to address the issue of manufacturer monopolies and price-gouging. To see a world health leader taking this stance is extremely disheartening. Not to mention, civil society groups, including T1International, have coordinated actions to address the root causes of the issue. If the application is rejected for a third time, the diabetes community will continue to feel that the voices of people with diabetes do not matter and that the WHO is not listening to those who live this reality every day. Read more
Underrepresented Communities and Navigating the System
14 Jun 2021, 12:52 p.m. in #insulin4all USA, Global Stories by Alzahrra Almajid
Seven years after my diagnosis my brother was also diagnosed with type 1 diabetes which made the already bad financial burden worse. Although all people with diabetes struggle with how expensive diabetes can be, immigrants and people of color often do not have access to quality health insurance (or any access) so they are less likely to benefit from advanced diabetes technology. As I got older I began to understand how difficult it is to navigate a system that makes it harder for people in underrepresented communities to get adequate care. Read more
From Patient to Medical Student: My Journey with Diabetes Treatment
8 Jun 2021, 9:03 a.m. in Global Stories by Konstantina Taki
Having lived with type 1 diabetes for more than 12 years, I have experienced different aspects of the condition. First of all, as a patient, I approach diabetes from a personal view. I can also understand how the condition affects parents of children with diabetes. It's something new, demanding and difficult to handle. The last five years, as a medical student in Greece, I have seen diabetes from yet another more practical and scientific perspective. Read more
T1International Statement Endorsing H.R.3
2 Jun 2021, 9:59 a.m. in News & Statements
For years, T1International and our advocates have been calling on both state and federal legislators to take action to address exorbitant drug prices. American lives depend on real action. That’s why T1International USA endorses the Elijah E. Cummings Lower Drug Costs Now Act (H.R.3). Read more
T1International Launches 100 Years: From Gift to Greed Campaign
17 May 2021, 11:04 a.m. in News & Statements by T1International
On Monday, May 17th - 100 years after Banting, Best and Macleod begin their first experiment trying to extract insulin in Toronto - T1International and its advocates around the world launch their year-long campaign. 100 Years: From Gift to Greed will tell the story of insulin’s discovery and how it went from being a gift to the world to a profit machine for the pharmaceutical industry. The campaign will be led by a combination of social media education and a variety of actions. Read more
Why MODY Should be Included in #insulin4all
28 Apr 2021, 1:27 p.m. in #insulin4all USA by Kylie Hanson Kulwicki
Most people don’t know the difference between type 1 and type 2 diabetes, let alone that there are more than 2 types. I have a form of diabetes called Maturity Onset Diabetes of the Young, or MODY for short. MODY is a genetic form of diabetes caused by a gene mutation or a gene deletion. Read more
Type 1 Diabetes, Disability, and the Role of Legislation in Advocacy
9 Apr 2021, 11:48 a.m. in Global Stories by Pramita Jasuja
It is through the recognition of injustices and assertion of our rights that we can ensure equal opportunities. T1D advocacy is emerging in India and as a collective we are highlighting these issues. Change is happening. In 2020 in Kerala High Court, a public interest litigation was filed over the issue of including T1D in the list of disabilities and creating a national registry for people with T1D. Read more
Insulin is a Right for Incarcerated People with Diabetes
24 Mar 2021, 9:06 a.m. in #insulin4all USA, Global Stories by Elana Megerian
It is time to recognize that incarcerated people with diabetes are particularly vulnerable to insulin insecurity. #insulin4all is more than a hashtag: It is a rallying call to everyone impacted by insulin inaccessibility, and a mournful cry for all who have lost their lives while insulin remains clearly in view, but cruelly out of reach. It’s a demand for justice for everyone who needs insulin to survive, including incarcerated people with diabetes. We must find ways to meaningfully include and involve this population in our activism. Read more